|
KIF15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.062450E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.790000E-02 |
| Normal-vs-Stage2 |
9.952800E-01 |
| Normal-vs-Stage3 |
1.949620E-01 |
| Normal-vs-Stage4 |
2.274800E-01 |
| Stage1-vs-Stage2 |
1.731980E-02 |
| Stage1-vs-Stage3 |
3.424200E-01 |
| Stage1-vs-Stage4 |
4.947000E-01 |
| Stage2-vs-Stage3 |
1.203780E-01 |
| Stage2-vs-Stage4 |
1.453810E-01 |
| Stage3-vs-Stage4 |
9.570200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.048500E-02 |
| Normal-vs-AfricanAmerican |
5.488600E-01 |
| Normal-vs-Asian |
7.552100E-02 |
| Caucasian-vs-AfricanAmerican |
4.977600E-01 |
| Caucasian-vs-Asian |
5.477600E-01 |
| AfricanAmerican-vs-Asian |
3.196000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.550500E-02 |
| Normal-vs-Female |
1.720440E-01 |
| Male-vs-Female |
1.571190E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.160400E-03 |
| Normal-vs-Age(41-60Yrs) |
6.473600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.839600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.764340E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.611400E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.262500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.680400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.603800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.933800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.432390E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.272200E-01 |
| Classical-VS-Follicular |
8.978700E-03 |
| Classical-VS-Other |
9.092200E-01 |
| Classical-VS-Normal |
1.802120E-02 |
| Tall-VS-Follicular |
3.457200E-01 |
| Tall-VS-Other |
7.420800E-01 |
| Tall-VS-Normal |
2.813400E-01 |
| Follicular-VS-Other |
4.270400E-01 |
| Follicular-VS-Normal |
7.616000E-01 |
| Other-VS-Normal |
4.642000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.754800E-01 |
| Normal-vs-N1 |
2.049800E-01 |
| N0-vs-N1 |
6.744600E-01 |
|
|
